Which closed-end funds own BridgeBio Oncology Therapeutics Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $4.4M. Security type: common equity. Country: United States. CUSIP 107924102 · ISIN US1079241022 · ticker BBOT.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.19% | $2M | 263,669 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| RMT Royce Micro-Cap Trust | U.S. Equity | 0.17% | $1.6M | 210,854 sh | $938M | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.08% | $457K | 60,030 sh | $573M | 3.7% discount | Jun 30, 2026 |
| RVT Royce Small-Cap Trust | U.S. Equity | 0.01% | $341K | 44,789 sh | $2.6B | 14.0% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “BBOT” → · Compare two funds’ portfolios →